Literature DB >> 22042014

Local resection of uveal melanoma.

Bertil E Damato1.   

Abstract

Local resection of uveal melanoma is aimed at conserving the eye and useful vision while removing any threat of metastatic spread. The tumour can be removed en bloc through a scleral opening (i.e., 'exoresection') or in a piecemeal fashion with a vitreous cutter passed through the retina (i.e., 'endoresection'). Variations of exoresection include iridectomy, iridocyclectomy, cyclochoroidectomy, and choroidectomy. Endoresection can be performed through a retinotomy or under a large retinal flap. Both exoresection and endoresection can be undertaken as a primary procedure, or after other conservative therapy as treatment for recurrent or toxic tumour. Each can be performed in combination with some form of radiotherapy, which can precede or follow the surgical resection. Endoresection should be relatively straightforward for experienced vitreoretinal surgeons; however, exoresection is more challenging, particularly with large and posterior tumours, because of the need for hypotensive anaesthesia and other measures to control intra-operative haemorrhage. In addition to their technical complexities, exoresection and endoresection are limited by intuitive concerns regarding iatrogenic tumour dissemination. When these obstacles are overcome, local resection preserves eyes that would otherwise be inoperable and produces relatively large tumour samples, which are useful for prognostication and research and which may one day have therapeutic value.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 22042014     DOI: 10.1159/000328261

Source DB:  PubMed          Journal:  Dev Ophthalmol        ISSN: 0250-3751


  13 in total

1.  Facile and efficient reprogramming of ciliary body epithelial cells into induced pluripotent stem cells.

Authors:  Aiguo Ni; Ming Jing Wu; Yuka Nakanishi; Sai H Chavala
Journal:  Stem Cells Dev       Date:  2013-06-05       Impact factor: 3.272

2.  Sphere formation permits Oct4 reprogramming of ciliary body epithelial cells into induced pluripotent stem cells.

Authors:  Aiguo Ni; Ming Jing Wu; Sai H Chavala
Journal:  Stem Cells Dev       Date:  2014-12-15       Impact factor: 3.272

3.  Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.

Authors:  Alexander Böker; Daniel Pilger; Dino Cordini; Ira Seibel; Aline I Riechardt; Antonia M Joussen; Nikolaos E Bechrakis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-16       Impact factor: 3.117

4.  The surgical approach to the management of anterior uveal melanomas.

Authors:  I Rospond-Kubiak; B Damato
Journal:  Eye (Lond)       Date:  2014-04-11       Impact factor: 3.775

5.  Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma.

Authors:  Ira Seibel; Dino Cordini; Annette Hager; Johanna Tillner; Aline I Riechardt; Jens Heufelder; Anja M Davids; Matus Rehak; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-07-04       Impact factor: 3.117

Review 6.  Personalized treatment of uveal melanoma.

Authors:  B Damato; H Heimann
Journal:  Eye (Lond)       Date:  2012-11-23       Impact factor: 3.775

Review 7.  Effects of radiotherapy on uveal melanomas and adjacent tissues.

Authors:  C Groenewald; L Konstantinidis; B Damato
Journal:  Eye (Lond)       Date:  2012-11-30       Impact factor: 3.775

Review 8.  Partial lamellar sclerouvectomy surgery for anteriorly located uveal tumour resection: a 20-year experience.

Authors:  Ibadulla Mirzayev; Ahmet Kaan Gündüz; Aylin Okçu Heper
Journal:  Eye (Lond)       Date:  2021-05-03       Impact factor: 4.456

9.  Caveolin-1 is a risk factor for postsurgery metastasis in preclinical melanoma models.

Authors:  Lorena Lobos-Gonzalez; Lorena Aguilar-Guzmán; Jaime G Fernandez; Nicolas Muñoz; Mehnaz Hossain; Simone Bieneck; Veronica Silva; Veronica Burzio; Elena V Sviderskaya; Dorothy C Bennett; Lisette Leyton; Andrew F G Quest
Journal:  Melanoma Res       Date:  2014-04       Impact factor: 3.599

10.  MicroRNAs in vitreus humor from patients with ocular diseases.

Authors:  Marco Ragusa; Rosario Caltabiano; Andrea Russo; Lidia Puzzo; Teresio Avitabile; Antonio Longo; Mario D Toro; Cinzia Di Pietro; Michele Purrello; Michele Reibaldi
Journal:  Mol Vis       Date:  2013-02-20       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.